A detailed history of Entry Point Capital, LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 1,794 shares of SLP stock, worth $51,433. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,794
Previous 1,393 28.79%
Holding current value
$51,433
Previous $57.3 Million 52.16%
% of portfolio
0.13%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$38.46 - $50.95 $15,422 - $20,430
401 Added 28.79%
1,794 $87.2 Million
Q1 2024

May 14, 2024

BUY
$37.48 - $44.74 $52,209 - $62,322
1,393 New
1,393 $57.3 Million

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $582M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.